| Literature DB >> 21573144 |
Sitali P Simwami1, Kantarawee Khayhan, Daniel A Henk, David M Aanensen, Teun Boekhout, Ferry Hagen, Annemarie E Brouwer, Thomas S Harrison, Christl A Donnelly, Matthew C Fisher.
Abstract
The global burden of HIV-associated cryptococcal meningitis is estimated at nearly one million cases per year, causing up to a third of all AIDS-related deaths. Molecular epidemiology constitutes the main methodology for understanding the factors underpinning the emergence of this understudied, yet increasingly important, group of pathogenic fungi. Cryptococcus species are notable in the degree that virulence differs amongst lineages, and highly-virulent emerging lineages are changing patterns of human disease both temporally and spatially. Cryptococcus neoformans variety grubii (Cng, serotype A) constitutes the most ubiquitous cause of cryptococcal meningitis worldwide, however patterns of molecular diversity are understudied across some regions experiencing significant burdens of disease. We compared 183 clinical and environmental isolates of Cng from one such region, Thailand, Southeast Asia, against a global MLST database of 77 Cng isolates. Population genetic analyses showed that Thailand isolates from 11 provinces were highly homogenous, consisting of the same genetic background (globally known as VNI) and exhibiting only ten nearly identical sequence types (STs), with three (STs 44, 45 and 46) dominating our sample. This population contains significantly less diversity when compared against the global population of Cng, specifically Africa. Genetic diversity in Cng was significantly subdivided at the continental level with nearly half (47%) of the global STs unique to a genetically diverse and recombining population in Botswana. These patterns of diversity, when combined with evidence from haplotypic networks and coalescent analyses of global populations, are highly suggestive of an expansion of the Cng VNI clade out of Africa, leading to a limited number of genotypes founding the Asian populations. Divergence time testing estimates the time to the most common ancestor between the African and Asian populations to be 6,920 years ago (95% HPD 122.96 - 27,177.76). Further high-density sampling of global Cng STs is now necessary to resolve the temporal sequence underlying the global emergence of this human pathogen.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21573144 PMCID: PMC3089418 DOI: 10.1371/journal.ppat.1001343
Source DB: PubMed Journal: PLoS Pathog ISSN: 1553-7366 Impact factor: 6.823
The allelic profiles of the 183 Cng isolates from Thailand typed by MLST in this study.
| Name | CAP59 allele(501 bp) | GPD1allele(489 bp) | IGS1 allele(709 bp) | LAC1 allele(471 bp) | PLB1 allele(533 bp) | SOD1 allele(527 bp) | URA5 allele(637 bp) | ST | Strain origin (if known) |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, blood |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Lampang, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Songkhla, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Songkhla, Thailand, blood |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Songkhla, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Khon Kaen, Thailand, crypto patient |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, pigeon dropping |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, dove dropping |
|
| 1 | 1 |
| 3 | 2 |
| 5 | 44 | Chiang Mai, Thailand, dove dropping |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Thailand, BAL |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Lampang, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Tak, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Lampoon, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Lampoon, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Nan, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Nan, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Songkhla, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Songkhla, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Pattani, Thailand, blood/HIV- |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Pattani, Thailand, blood/HIV- |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Pattani, Thailand, blood |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, crypto patient |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, crypto patient |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, crypto patient |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, dove dropping |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, dove dropping |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, pigeon dropping |
|
| 1 | 1 |
| 4 | 2 |
| 5 | 45 | Chiang Mai, Thailand, pigeon dropping |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Khon Kaen, Thailand, clinical |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Khon Kaen, Thailand, clinical |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Khon Kaen, Thailand, clinical |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, crypto patient |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, dove dropping |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, pigeon dropping |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Rai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Rai, Thailand, blood |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Rai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Rai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Rai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Mae Hong Son, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
| 5 | 2 |
| 1 | 46 | Chiang Mai, Thailand, CSF |
|
| 1 | 3 |
|
| 2 |
| 1 | 53 | Nan, Thailand, clinical |
|
| 1 | 1 |
| 5 | 2 |
| 1 | 51 | Chiang Mai, Thailand, crypto patient |
|
| 1 | 1 |
| 3 | 4 |
| 1 | 47 | Chiang Rai, Thailand, CSF |
|
| 1 | 1 |
| 3 | 4 |
| 1 | 47 | Pattani, Thailand, blood/HIV- |
|
| 1 | 1 |
| 3 | 4 |
| 1 | 47 | Ubon Ratchathani, Thailand, CSF |
|
| 1 | 1 |
| 3 | 4 |
| 5 | 50 | Khon Kaen, Thailand, crypto patient |
|
| 1 | 1 |
|
| 2 |
| 5 | 52 | Khon Kaen, Thailand, clinical |
|
| 1 | 1 |
| 4 | 2 |
|
| 49 | Chiang Mai, Thailand, dove dropping |
|
| 2 | 10 |
| 6 | 11 |
| 4 | 48 | Ubon Ratchathani, Thailand, CSF |
bp = base pairs; crypto patient = cryptococcosis patient; novel ATs are in bold.
Figure 1eBURST illustration comparing the isolates from Thailand with the global population of Cng used in this study.
No. isolates = 176, no. STs = 53, no. re-samplings for bootstrapping = 1000, no. loci per isolate = 7, no. identical loci for group def = 1, no. groups = 1. STs identified by eBURST as present in Thailand and elsewhere in the global dataset are highlighted pink text, those only found in Thailand highlighted green and those only in the global population and not in Thailand are black. Founding genotypes are in blue, and the size of the dots are representative of the number of isolates of that ST.
Summary of AMOVA of Cng isolates, based on the seven polymorphic loci and according to geographical origin.
| d.f. | Sum of squares | Variance components (%) | ΦPT |
| |
| (i) Thai population: North ( | |||||
| Among populations | 2 | 4 | 0.03 (5) | 0.05 | 0.013 |
| Within populations | 176 | 114 | 0.65 (95) | ||
| Total | 178 | 118 | 0.68 (100) | ||
| (ii) Asian and Global populations: Asia ( | |||||
| Among populations | 1 | 12 | 1.22 (49) | 0.49 | 0.010 |
| Within populations | 259 | 333 | 1.28 (51) | ||
| Total | 260 | 459 | 2.51 (100) | ||
| (iii) Global population | |||||
| Among populations | 3 | 145 | 1.29 (52) | 0.52 | 0.001 |
| Within populations | 255 | 308 | 1.21 (48) | ||
| Total | 258 | 452 | 2.5 (100) | ||
P - value estimates are based on 999 permutations.
Europe was excluded due to small sample size (n = 2).
Figure 2Principle Components Analysis of the allelic profiles of the Thai Cng genotypes typed in this study.
Individual genotypes (dots) are linked by coloured lines to form clusters which are summarised by coloured ellipses proportional in size to the number of isolates represented. The three groups depicted are numbered and defined according to Thai region: 1 = North (red; n = 91), 2 = Northeast (blue; n = 79) and 3 = South (purple; n = 9). P - value is shown and eigenvalues represented in the bar plot.
Figure 3Neighbour-joining tree inferring the evolutionary relationships of the Thai isolates typed in this study (n = 183).
Each circle represents a Sequence Type (ST) of the Thai isolates and is proportional in size to the number of isolates of this ST. The isolates are grouped according to three regions of Thailand, Northern province in dark blue (n = 91), Northeastern province in light blue (n = 79) and Southern province in red (n = 9). The four Thai isolates of unknown origin are in black (n = 4). The percentage replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) more than 70% of the time (n≥70%) are indicated. The evolutionary distances were computed using the Maximum Composite Likelihood method and are in the units of the number of base substitutions per site.
Figure 4Principle Components Analysis of the allelic profiles of the global Cng genotypes analysed in this study.
Individual genotypes (dots) are linked by coloured lines to form clusters which are summarised by coloured ellipses proportional in size to the number of isolates represented. The four groups are numbered and defined according continent: 1 = Asia (pink; n = 191), 2 = South America (grey; n = 5), 3 = North America (light blue; n = 19), 4 = Africa (dark blue; n = 44). P - value is shown and eigenvalues represented in the bar plot.
Figure 5Neighbour-joining tree inferring the evolutionary relationships of the global Cng isolates included in this study (n = 261).
The geographical origins of the isolates are represented by coloured rectangles: green = Africa (n = 44), red = Thailand (isolates typed in this study; n = 186), purple = remaining Asian isolates (n = 5), dark blue = North America (n = 19), light blue = South America (n = 5) and yellow = Europe (n = 2). Black rectangles represent reference strains of known VN molecular types that are detailed on the figure for VNI (WM148, H99; n = 232), VNII (WM626; n = 11) and VNB (n = 21). Reference strains of the C. gattii complex (molecular groups VGI – IV) are labelled and serve as an outgroup: WM179, WM178, WM175 and WM779. The percentage replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are indicated if supported by significant bootstrap values (n≥80%). The evolutionary distances were computed using the Maximum Composite Likelihood method and are in the units of the number of base substitutions per site.
Multilocus linkage disequilibrium analyses for samples of Cn var grubii.
| Population | Total sample | Population | Clone-corrected sample | ||||
|
|
| PcP |
|
| PcP | ||
| Africa( | 1.67 | 0.28 | 0.43 | Africa( | 1.25 | 0.21 | 0.43 |
| Asia( | 1.54 | 0.30 | 0.67 | Asia( | 1.11 | 0.19 | 0.67 |
| North America( | 3.45 | 0.58 | 1 | North America( | 2.13 | 0.36 | 1 |
| Global ( | 3.18 | 0.53 | 0.19 | Global ( | 1.53 | 0.53 | 0.38 |
excluding replicate haplotypes;
index of association;
scaled index of association (I A) by the number of loci (m – 1);
percentage of phylogenetically compatible pairs (PcP) of loci.
***P<0.001.
The South American and European populations were not individually analyzed due to their sample sizes being too small (n = 5 and 2, respectively), but were included in the global population (n = 261).
Polymorphism summary and tests neutral evolution for groups of isolates of Cn var grubii according to geographic origin.
| Locus | pb | S |
|
|
|
| D | R2
| Rm | |
| Africa ( |
| 501 | 11 | 10 | 0.82 | 0.004 | 0.005 | -0.79ns | 0.08ns | 1 |
|
| 489 | 16 | 11 | 0.82 | 0.006 | 0.008 | -0.55ns | 0.09ns | 0 | |
|
| 704 | 22 | 12 | 0.83 | 0.006 | 0.007 | -0.50ns | 0.10ns | 2 | |
|
| 470 | 12 | 8 | 0.75 | 0.006 | 0.006 | 0.03ns | 0.11ns | 0 | |
|
| 533 | 15 | 11 | 0.8 | 0.004 | 0.006 | -1.09ns | 0.07ns | 1 | |
|
| 524 | 24 | 10 | 0.64 | 0.011 | 0.011 | 0.30ns | 0.12ns | 1 | |
|
| 636 | 24 | 12 | 0.86 | 0.008 | 0.009 | -0.43ns | 0.10ns | 1 | |
| Average | 0.79 | 0.007 | 0.007 | 12 | ||||||
| Asia ( |
| 501 | 5 | 2 | 0.01 | 0.0001 | 0.002 | -1.81 | 0.07ns | 0 |
|
| 489 | 6 | 3 | 0.28 | 0.0007 | 0.002 | -1.40ns | 0.06ns | 0 | |
|
| 707 | 11 | 3 | 0.06 | 0.0008 | 0.003 | -1.71ns | 0.03ns | 0 | |
|
| 474 | 61 | 6 | 0.64 | 0.0031 | 0.022 | -2.62 | 0.06ns | 2 | |
|
| 533 | 8 | 4 | 0.07 | 0.0003 | 0.003 | -1.97 | 0.05ns | 0 | |
|
| 526 | 11 | 2 | 0.01 | 0.0002 | 0.004 | -2.25 | 0.07ns | 0 | |
|
| 637 | 10 | 4 | 0.33 | 0.0007 | 0.003 | -1.78 | 0.06ns | 0 | |
| Average | 0.2 | 0.0001 | 0.005 | 5 | ||||||
| North America ( |
| 501 | 8 | 5 | 0.78 | 0.006 | 0.005 | 1.39ns | 0.20ns | 0 |
|
| 489 | 7 | 5 | 0.76 | 0.006 | 0.004 | 1.28ns | 0.20ns | 0 | |
|
| 708 | 16 | 6 | 0.77 | 0.008 | 0.006 | 1.09ns | 0.18ns | 2 | |
|
| 471 | 9 | 5 | 0.8 | 0.008 | 0.005 | 1.77ns | 0.22ns | 0 | |
|
| 533 | 9 | 5 | 0.81 | 0.007 | 0.005 | 1.65ns | 0.21ns | 0 | |
|
| 526 | 12 | 4 | 0.57 | 0.01 | 0.007 | 1.80ns | 0.21ns | 0 | |
|
| 637 | 9 | 4 | 0.75 | 0.006 | 0.004 | 2.06 | 0.23ns | 0 | |
| Average | 0.75 | 0.007 | 0.005 | 4 | ||||||
| South America ( |
| 501 | 1 | 2 | 0.6 | 0.001 | 0.001 | 1.22ns | 0.3ns | 0 |
|
| 489 | 0 | 1 | 0 | 0 | 0 | ND | ND | ND | |
|
| 709 | 43 | 2 | 0.6 | 0.037 | 0.03 | 1.88 | 0.3ns | 0 | |
|
| 470 | 2 | 2 | 0.6 | 0.003 | 0.002 | 1.46ns | 0.3ns | 0 | |
|
| 533 | 1 | 2 | 0.6 | 0.001 | 0.001 | 1.22ns | 0.3ns | 0 | |
|
| 527 | 0 | 1 | 0 | 0 | 0 | ND | ND | ND | |
|
| 637 | 1 | 2 | 0.6 | 0.001 | 0.001 | 1.22ns | 0.3ns | 0 | |
| Average | 0.4 | 0.006 | 0.005 | 0 | ||||||
total number of sites in alignments, excluding indels and missing data;
number of segregating sites;
number of haplotypes;
haplotypic diversity;
average number of nucleotide differences per site;
Watterson's estimate of the population scaled mutation rate, expressed per site [95];
Tajima's D [62];
Ramos-Onsins & Rozas' R2 [99];
minimum number of recombination events [61];
average Rm = Rm between all seven loci; ND not determined because of no polymorphism. ns non-significant (P>0.05),
*P<0.05, **P<0.01, **P<0.001.
(A) Divergence among the sub-populations of the global Cng isolates. (B) Differentiation between sub-populations of the global Cng isolates.
| A. | Africa - Asia | Asia - North America | Asia - South America | Africa - North America | Africa - South America | North America - South America | ||||||||||||
| Locus | Dxy
| Sf
| Ss | Dxy | Sf | Ss | Dxy | Sf | Ss | Dxy | Sf | Ss | Dxy | Sf | Ss | Dxy | Sf | Ss |
| CAP59 | 0.003 | 0 | 3 | 0.005 | 0 | 1 | 0.001 | 0 | 0 | 0.006 | 0 | 6 | 0.003 | 0 | 1 | 0.005 | 0 | 1 |
| GPD1 | 0.007 | 0 | 5 | 0.005 | 0 | 5 | 0.003 | 0 | 0 | 0.007 | 0 | 6 | 0.005 | 0 | 0 | 0.004 | 0 | 0 |
| IGS1 | 0.004 | 0 | 13 | 0.008 | 0 | 13 | 0.008 | 0 | 9 | 0.009 | 0 | 13 | 0.009 | 0 | 9 | 0.009 | 0 | 9 |
| LAC1 | 0.006 | 0 | 4 | 0.008 | 0 | 2 | 0.004 | 0 | 0 | 0.008 | 0 | 9 | 0.005 | 0 | 2 | 0.007 | 0 | 2 |
| PLB1 | 0.004 | 0 | 8 | 0.006 | 0 | 8 | 0.003 | 0 | 1 | 0.006 | 0 | 8 | 0.003 | 0 | 1 | 0.005 | 0 | 1 |
| SOD1 | 0.008 | 0 | 11 | 0.008 | 0 | 12 | 0.000 | 0 | 0 | 0.013 | 0 | 11 | 0.008 | 0 | 0 | 0.008 | 0 | 0 |
| URA5 | 0.007 | 0 | 9 | 0.006 | 0 | 8 | 0.002 | 0 | 0 | 0.001 | 0 | 9 | 0.006 | 0 | 1 | 0.005 | 0 | 1 |
|
| 0.005 | 0 | 53 | 0.006 | 0 | 49 | 0.003 | 0 | 10 | 0.007 | 0 | 62 | 0.006 | 0 | 14 | 0.006 | 0 | 14 |
|
| Africa | Asia | N. America | S. America | ||||||||||||||
| Africa | 0.11 | 0.03 | 0.01ns | |||||||||||||||
| Asia |
| 0.08 | 0.04 | |||||||||||||||
| N. America |
|
| 0.02ns | |||||||||||||||
| S. America |
|
|
| |||||||||||||||
The isolates are subdivided by continent: Africa (n = 44), Asia (n = 191), North and South America (n = 19 and 5, respectively).
minimum estimate of the number of nucleotide differences per site between groups;
number of fixed differences between groups;
number of shared polymorphisms between groups.
K values are displayed above the diagonal and represent the weighted measure of the ratio of the average pair-wise differences within groups to the total average pair-wise differences.
S values are displayed below the diagonal and in bold and represent the proportion of nearest neighbours in sequence space that are found in the same group.
Significance levels for KST and Snn were assessed using permutation tests, with 1000 permutations:
ns = non-significant, **P<0.01, ***P<0.001.
Europe has been excluded as it contains only two isolates.
Bayesian estimates of time (in years) to the most recent common ancestor of Cng populations, according to geographic location, calculated under the assumption of three mutation rates and adopting the relaxed uncorrelated lognormal molecular clock model as implemented in BEAST v.1.4.1.
| TMRCA | Mutation rates per site per year | ||
| 0.9×10 -9 | 8.8×10 -9 | 16.7×10 -9 | |
| Africa/Asia | 6,921 | 60,572 | 1.05×10 6 |
| 95% HPDI | (123 - 27,178) | (28 - 2.8×105) | (3.8×105-2.0×106) |
| ESS | 58.9 | 22.9 | 44.1 |
| Global | 7,103 | 60,739 | 1.05×106 |
| 95% HPDI | (123 - 27,178) | (28-2.8×10 5) | (3.8×105-2.0×10 6) |
| ESS | 57.0 | 22.8 | 44.0 |
ESS = Effective sample size.
95% HPDI = 95% highest posterior densities intervals.
Figure 6Haplotype networks of the 53 STs of the global Cng population at each of the seven loci.
Sampled haplotypes are indicated by circles or rectangles colored according to the geographical region from which the sample was collected. STs unique to the African population are shown in green and consist only of clinical isolates. Haplotypes found both in Africa and elsewhere are in brown, while those not found in Africa are represented in blue. Rectangles depict the haplotype with the highest ancestral probability. Each branch indicates a single mutational difference and black dots on the lines are representative of the number of mutational steps required to generate allelic polymorphisms. Circle size is proportional to observed haplotype frequency.